Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Institut für Klinische Chemie und Laboratoriumsmedizin

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Kruger, R; Tholey, A; Jakoby, T et al.

QUANTIFICATION OF THE FABRY MARKER LYSOGB3 BY TANDEM MASS SPECTROMETRY

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. Bd. 49. 2011 S. S764-S764


Deufel, T; Geßler, R; Kiehntopf, M et al.

Richtlinie: Labormedizinische Diagnostik bei der Therapie mit TPMT (Thiopurin-S-Methyltransferase)-abhängigen Pharmaka

LaboratoriumsMedizin. Bd. 28. H. 12. 2011 S. 477-482


Keller, T; Zeller, T; Ojeda, F et al.

Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Bd. 306. H. 24. 2011 S. 2684-2693


Prinz, N; Hauser, F; Lorenz, M et al.

Structural and functional characterization of a human IgG monoclonal antiphospholipid antibody

IMMUNOBIOLOGY. Bd. 216. H. 1-2. 2011 S. 145-151


Tadic, A; Wagner, S; Schlicht, KF et al.

The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. Bd. 35. H. 2. 2011 S. 415-420



Zimmermann, A; Grigorescu-Sido, P; AlKhzouz, C et al.

Alterations in Lipid and Carbohydrate Metabolism in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

HORMONE RESEARCH IN PAEDIATRICS. Bd. 74. H. 1. 2010 S. 41-49


Henninger, C; Hulsenbeck, J; Hamalukic, M et al.

Beneficial effects of the HMG-CoA reductase inhibitor lovastatin on ionizing radiation- and doxorubicin-induced cytotoxicity in vivo

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 381. 2010 S. 42-42


Lackner, KJ

Biomarkers of cardiovascular risk - matters of prediction and precision

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. Bd. 48. H. 12. 2010 S. 1683-1684


Yakushev, I; Bartenstein, P; Siessmeier, T et al.

Cerebrospinal Fluid Tau Protein Levels and F-18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer's Disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. Bd. 30. H. 3. 2010 S. 245-253